{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:47:10Z","timestamp":1767340030400},"reference-count":28,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Common variable immunodeficiency (CVID) is a heterogeneous group of disorders characterized by hypogammaglobulinemia and increased susceptibility to recurrent pyogenic infections. This study was performed to subclassify CVID on the basis of the bactericidal antibody responses of patients to polysaccharide meningococcal vaccine. Twenty-five patients with CVID (18 male and 7 female) and 25 healthy volunteers received meningococcal polysaccharide vaccine A + C. Serum bactericidal antibody (SBA) titers were measured at baseline and after 3 weeks. Response was correlated with clinical and immunological manifestations of CVID. Twenty-four (96%) of the 25 normal controls had a protective SBA titer of \u22658 postvaccination, whereas only 16 (64%) of the 25 CVID patients had a protective titer (\n            <jats:italic>P<\/jats:italic>\n            value = 0.013). Among the patients with CVID who were nonresponders, there were significantly increased rates of bronchiectasis (\n            <jats:italic>P<\/jats:italic>\n            = 0.008), splenomegaly (\n            <jats:italic>P<\/jats:italic>\n            = 0.016), and autoimmunity (\n            <jats:italic>P<\/jats:italic>\n            = 0.034) in comparison with patients who had protective SBA titers. A reversed CD4\/CD8 ratio was more common in the nonresponder group of patients (\n            <jats:italic>P<\/jats:italic>\n            = 0.053). We conclude that individuals with CVID who cannot produce protective postvaccination titers after receiving meningococcal polysaccharide vaccine are more likely to exhibit bronchiectasis, splenomegaly, and autoimmune diseases. Vaccination response may define subgroups of patients with CVID, enabling more effective monitoring and therapeutic strategies.\n          <\/jats:p>","DOI":"10.1128\/cvi.00489-07","type":"journal-article","created":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T02:19:01Z","timestamp":1201745941000},"page":"607-611","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":31,"title":["Serum Bactericidal Antibody Responses to Meningococcal Polysaccharide Vaccination as a Basis for Clinical Classification of Common Variable Immunodeficiency"],"prefix":"10.1128","volume":"15","author":[{"given":"Nima","family":"Rezaei","sequence":"first","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Davar","family":"Siadat","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Moin","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Pourpak","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Nejati","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojat","family":"Ahmadi","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samineh","family":"Kamali","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariush","family":"Norouzian","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Tabaraei","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Read","sequence":"additional","affiliation":[{"name":"Immunology, Asthma and Allergy Research Institute, Medical Sciences\/University of Tehran, Tehran, Iran"},{"name":"Section of Infection, Inflammation and Immunity, School of Medicine and Biomedical Sciences, The University of Sheffield, Sheffield, United Kingdom"},{"name":"Department of Bacterial Vaccine and Antigen Production, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"825","volume":"12","year":"2005","unstructured":"Aghamohammadi, A., A. Farhoudi, M. Moin, N. Rezaei, A. Kouhi, Z. Pourpak, N. Yaseri, M. Movahedi, M. Gharagozlou, F. Zandieh, F. Yazadni, S. Arshi, I. Mohammadzadeh, B. M. Ghazi, M. Mahmoudi, S. Tahaei, and A. Isaeian. 2005. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin. Diagn. Lab. Immunol.12:825-832.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000095469","volume":"141","year":"2006","unstructured":"Aghamohammadi, A., M. Fiorini, M. Moin, N. Parvaneh, S. Teimourian, M. Yeganeh, F. Goffi, H. Kanegane, A. A. Amirzargar, Z. Pourpak, N. Rezaei, A. Salavati, N. Pouladi, S. Abdollahzade, L. D. Notarangelo, T. Miyawaki, and A. Plebani. 2006. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int. Arch. Allergy Immunol.141:408-414.","journal-title":"Int. Arch. Allergy Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1023\/A:1020660416865","volume":"22","year":"2002","unstructured":"Aghamohammadi, A., M. Moein, A. Farhoudi, Z. Pourpak, N. Rezaei, K. Abolmaali, M. Movahedi, M. Gharagozlou, B. M. Ghazi, M. Mahmoudi, D. Mansouri, S. Arshi, N. J. Trash, H. Akbari, R. Sherkat, R. F. Hosayni, A. Hashemzadeh, I. Mohammadzadeh, R. Amin, S. Kashef, A. Alborzi, A. Karimi, and H. Khazaei. 2002. Primary immunodeficiency in Iran: first report of the National Registry of PID in Children and Adults. J. Clin. Immunol.22:375-380.","journal-title":"J. Clin. Immunol."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0090-1229(90)90145-G","volume":"56","year":"1990","unstructured":"Bryant, A., N. C. Calver, E. Toubi, A. D. Webster, and J. Farrant. 1990. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin. Immunol. Immunopathol.56:239-248.","journal-title":"Clin. Immunol. Immunopathol."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jaci.2004.10.048","volume":"115","year":"2005","unstructured":"Carsetti, R., M. M. Rosado, S. Donnanno, V. Guazzi, A. Soresina, A. Meini, A. Plebani, F. Aiuti, and I. Quinti. 2005. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J. Allergy Clin. Immunol.115:412-417.","journal-title":"J. Allergy Clin. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0022-3476(86)80927-1","volume":"108","year":"1986","unstructured":"Conley, M. E., C. L. Park, and S. D. Douglas. 1986. Childhood common variable immunodeficiency with autoimmune disease. J. Pediatr.108:915-922.","journal-title":"J. Pediatr."},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11882-001-0027-1","volume":"1","year":"2001","unstructured":"Cunningham-Rundles, C. 2001. Common variable immunodeficiency. Curr. Allergy Asthma Rep.1:421-429.","journal-title":"Curr. Allergy Asthma Rep."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","year":"1999","unstructured":"Cunningham-Rundles, C., and C. Bodian. 1999. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol.92:34-48.","journal-title":"Clin. Immunol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10238-004-0027-2","volume":"3","year":"2004","unstructured":"Di Renzo, M., A. L. Pasqui, and A. Auteri. 2004. Common variable immunodeficiency: a review. Clin. Exp. Med.3:211-217.","journal-title":"Clin. Exp. Med."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1182\/blood.V84.12.4234.bloodjournal84124234","volume":"84","year":"1994","unstructured":"Fischer, M. B., I. Hauber, H. Eggenbauer, V. Thon, E. Vogel, E. Schaffer, J. Lokaj, J. Litzman, H. M. Wolf, J. W. Mannhalter, and M. M. Eibl. 1994. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood84:4234-4241.","journal-title":"Blood"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jaci.2007.08.053","volume":"120","year":"2007","unstructured":"Geha, R. S., L. Notarangelo, J. L. Casanova, H. Chapel, M. E. Conley, A. Fischer, L. Hammarstrom, S. Nonoyama, H. Ochs, J. Puck, C. Roifman, R. Seger, and J. Wedgwood. 2007. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol.120:776-794.","journal-title":"J. Allergy Clin. Immunol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.all.0000191888.97397.b3","volume":"5","year":"2005","unstructured":"Goldacker, S., and K. Warnatz. 2005. Tackling the heterogeneity of CVID. Curr. Opin. Allergy Clin. Immunol.5:504-509.","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","volume":"120","year":"2000","unstructured":"Hammarstr\u00f6m, L., I. Vorechovsky, and D. Webster. 2000. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin. Exp. Immunol.120:225-231.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2004-06-2423","volume":"105","year":"2005","unstructured":"Holm, A. M., P. Aukrust, J. K. Damas, F. Muller, B. Halvorsen, and S. S. Froland. 2005. Abnormal interleukin-7 function in common variable immunodeficiency. Blood105:2887-2890.","journal-title":"Blood"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clim.2005.03.019","volume":"116","year":"2005","unstructured":"Ko, J., L. Radigan, and C. Cunningham-Rundles. 2005. Immune competence and switched memory B cells in common variable immunodeficiency. Clin. Immunol.116:37-41.","journal-title":"Clin. Immunol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/cdli.4.2.156-167.1997"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2249.2002.02004.x","volume":"130","year":"2002","unstructured":"Mellemkjaer, L., L. Hammarstrom, V. Andersen, J. Yuen, C. Heilmann, T. Barington, J. Bjorkander, and J. H. Olsen. 2002. Cancer risk among patients with IgA deficiency or common variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin. Exp. Immunol.130:495-500.","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_3_2_19_2","first-page":"59","volume":"6","year":"2007","unstructured":"Nourizadeh, M., A. Aghamohammadi, S. M. Moazzeni, M. Mahdavi, N. Rezaei, and J. Hadjati. 2007. High production of IL-18 by dendritic cells induced by sera from patients with primary antibody deficiency. Iran. J. Allergy Asthma Immunol.6:59-65.","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"e_1_3_2_20_2","first-page":"1152","volume":"41","year":"2004","unstructured":"Pahari, A., C. Pal, and H. Lyall. 2004. Recurrent meningitis in association with common variable immune deficiency. Indian Pediatr.41:1152-1154.","journal-title":"Indian Pediatr."},{"key":"e_1_3_2_21_2","first-page":"129","volume":"6","year":"2007","unstructured":"Ravanbakhsh, M., A. Sarafnejad, A. Aghamohammadi, G. A. Kardar, H. Asgarian Omran, L. Atarod, N. Rezaei, T. Shahrestani, M. Hosseini, and M. Moin. 2007. CD40 ligand expression on stimulated T-helper lymphocytes in patients with common variable immunodeficiency. Iran. J. Allergy Asthma Immunol.6:129-135.","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10875-006-9047-x","volume":"26","year":"2006","unstructured":"Rezaei, N., A. Aghamohammadi, M. Moin, Z. Pourpak, M. Movahedi, M. Gharagozlou, L. Atarod, B. M. Ghazi, A. Isaeian, M. Mahmoudi, K. Abolmaali, D. Mansouri, S. Arshi, N. J. Tarash, R. Sherkat, H. Akbari, R. Amin, A. Alborzi, S. Kashef, R. Farid, I. Mohammadzadeh, M. S. Shabestari, M. Nabavi, and A. Farhoudi. 2006. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry. J. Clin. Immunol.26:519-532.","journal-title":"J. Clin. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1016\/j.vaccine.2007.05.021","volume":"25","year":"2007","unstructured":"Rezaei, N., A. Aghamohammadi, S. D. Siadat, M. Nejati, H. Ahmadi, M. Moin, Z. Pourpak, S. Kamali, D. Norouzian, B. Tabaraei, and R. C. Read. 2007. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine25:5308-5314.","journal-title":"Vaccine"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0897.2006.00409.x","volume":"56","year":"2006","unstructured":"Rezaei, N., Z. Pourpak, A. Aghamohammadi, A. Farhoudi, M. Movahedi, M. Gharagozlou, B. Mirsaeid Ghazi, L. Atarod, K. Abolmaali, M. Mahmoudi, D. Mansouri, S. Arshi, N. J. Tarash, R. Sherkat, R. Amin, S. Kashef, R. F. Hosseini, I. Mohammadzadeh, M. S. Shabestari, M. Nabavi, and M. Moin. 2006. Consanguinity in primary immunodeficiency disorders: the report from Iranian Primary Immunodeficiency Registry. Am. J. Reprod Immunol.56:145-151.","journal-title":"Am. J. Reprod Immunol."},{"key":"e_1_3_2_25_2","first-page":"321","volume":"17","year":"2007","unstructured":"Vodjgani, M., A. Aghamohammadi, M. Samadi, M. Moin, J. Hadjati, M. Mirahmadian, N. Parvaneh, A. Salavati, S. Abdollahzade, N. Rezaei, and A. Sarrafnejad. 2007. The study of switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J. Investig. Allergol. Clin. Immunol.17:321-328.","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood.V99.5.1544","volume":"99","year":"2002","unstructured":"Warnatz, K., A. Denz, R. Dr\u00e4ger, M. Braun, C. Groth, G. Wolff-Vorbeck, H. Eibel, M. Schlesier, and H. H. Peter. 2002. Severe deficiency of switched memory B cells (CD27+IgM\u2212IgD\u2212) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood99:1544-1551.","journal-title":"Blood"},{"key":"e_1_3_2_27_2","first-page":"103","volume":"3","year":"2004","unstructured":"Webster, A. D. B. 2004. Clinical and immunological spectrum of common variable immunodeficiency (CVID). Iran. J. Allergy Asthma Immunol.3:103-113.","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1182\/blood-2007-06-091744","volume":"111","year":"2008","unstructured":"Wehr, C., T. Kivioja, C. Schmitt, B. Ferry, T. Witte, E. Eren, M. Vlkova, M. Hernandez, D. Detkova, P. R. Bos, G. Poerksen, H. von Bernuth, U. Baumann, S. Goldacker, S. Gutenberger, M. Schlesier, F. Bergeron-van der Cruyssen, M. Le Garff, P. Debre, R. Jacobs, J. Jones, E. Bateman, J. Litzman, P. M. van Hagen, A. Plebani, R. E. Schmidt, V. Thon, I. Quinti, T. Espanol, A. D. Webster, H. Chapel, M. Vihinen, E. Oksenhendler, H. H. Peter, and K. Warnatz. 2008. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood111:77-85.","journal-title":"Blood"},{"key":"e_1_3_2_29_2","unstructured":"Standardization and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A\/C vaccines 1999"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00489-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00489-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:39:46Z","timestamp":1627591186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00489-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["10.1128\/CVI.00489-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00489-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]},"assertion":[{"value":"2007-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-01-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}